Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

Health, Fitness & Food

Eli Lilly’s office in La Jolla, California.
Konrad Fiedler | Bloomberg | Getty Images

The launch of Eli Lilly‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday.

Products You May Like

Articles You May Like

19 Early Black Friday Fitness Deals to Grab Before They Sell Out
2 health stocks are buys. They’ve been beaten up enough on Trump’s RFK Jr. pick for HHS
My First Contortion Class Was Humbling — Here’s What It Taught Me
Fitness Professionals Deal With Body Dysmorphia, Too. Here’s How They Heal.
I Tried the $7,500 a Month Gym. Is It Worth It?

Leave a Reply

Your email address will not be published. Required fields are marked *